Table 3.
Odds of Procedure Use and Mortality in HF and AMI Cohorts
aOR, COVID‐19 vs non‐COVID‐19 | Lower CI | Upper CI | P value | |
---|---|---|---|---|
AMI | ||||
Mortality (all) | 1.36 | 1.15 | 1.60 | <0.001 |
Mortality (STEMI) | 2.57 | 2.24 | 2.96 | <0.001 |
Left‐heart catheterization (all) | 1.02 | 0.88 | 1.19 | 0.77 |
Heart failure | ||||
Mortality | 1.01 | 0.89 | 1.15 | 0.91 |
Right‐heart catheterization | 1.07 | 0.92 | 1.25 | 0.36 |
Models control for age, race, insurance status, Elixhauser comorbidities, and season. The non‐COVID‐19 time periods serve as the reference group, such that odds ratios >1 indicate a higher odds of the event during COVID‐19.
AMI indicates acute myocardial infarction; aOR, adjusted odds ratio; and STEMI, ST‐segment–elevation myocardial infarction.